Medicare Enrolled
Dr. Songchuan Guo, M.D.
Hematology & Oncology · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Guo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Guo
Dr. Songchuan Guo is a hematology & oncology specialist in Brooklyn, NY, with 15 years of NPI registration. Based on federal Medicare data, Dr. Guo performed 1,651 Medicare services across 337 unique beneficiaries.
Between the years covered by Open Payments, Dr. Guo received a total of $106,852 from 66 pharmaceutical and/or device companies across 1015 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Guo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 34% volume in NY
$106,852 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,651
Medicare services
Top 34% in NY for hematology & oncology
337
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~110 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
280 | $8 | $16 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
234 | $80 | $151 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
191 | $8 | $16 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
178 | $113 | $213 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
162 | $125 | $232 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
140 | $27 | $65 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
116 | $1 | $3 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
110 | $15 | $55 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
81 | $62 | $138 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
73 | $13 | $40 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
42 | $1 | $1 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $136 | $274 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
22 | $73 | $135 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.8% high complexity
11.1% medium
56.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$106,852
Total received (2018-2024)
Avg $15,265/year across 7 years
Top 7% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
1,015
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$55,764 (52.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$30,759 (28.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,329 (19.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$10,578
2023
$17,889
2022
$13,801
2021
$16,817
2020
$32,074
2019
$11,654
2018
$4,038
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$6,523
Astellas Pharma US Inc
$402
Novartis Pharmaceuticals Corporation
$382
Merck Sharp & Dohme LLC
$314
PFIZER INC.
$291
Eisai Inc.
$290
Incyte Corporation
$264
AngioDynamics, Inc.
$260
Exelixis Inc.
$238
Janssen Biotech, Inc.
$190
E.R. Squibb & Sons, L.L.C.
$172
Takeda Pharmaceuticals U.S.A., Inc.
$121
Daiichi Sankyo Inc.
$101
BeiGene USA, Inc.
$99
PUMA BIOTECHNOLOGY, INC.
$93
Genmab U.S., Inc.
$82
EMD Serono, Inc.
$73
TAIHO ONCOLOGY, INC.
$72
Celgene Corporation
$62
GENZYME CORPORATION
$57
Aveo Pharmaceuticals, Inc.
$51
Lilly USA, LLC
$51
Bayer Healthcare Pharmaceuticals Inc.
$48
SOBI, INC
$48
Stemline Therapeutics Inc.
$45
Rigel Pharmaceuticals, Inc.
$28
ARRAY BIOPHARMA INC
$28
Regeneron Healthcare Solutions, Inc.
$27
Gilead Sciences, Inc.
$27
SHIELD THERAPEUTICS INC
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Mirati Therapeutics, Inc.
$24
Ipsen Biopharmaceuticals, Inc
$22
Sumitomo Pharma America, Inc.
$22
Agios Pharmaceuticals, Inc.
$17
Top 3 companies account for 69.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$45,852
Boehringer Ingelheim Pharmaceuticals, Inc.
$25,802
Eisai Inc.
$7,475
EISAI INC.
$3,565
ARRAY BIOPHARMA INC
$2,731
E.R. Squibb & Sons, L.L.C.
$2,320
Exelixis Inc.
$2,195
Novartis Pharmaceuticals Corporation
$1,770
Amgen Inc.
$1,751
PFIZER INC.
$1,250
Janssen Biotech, Inc.
$1,030
Incyte Corporation
$822
Merck Sharp & Dohme LLC
$779
Astellas Pharma US Inc
$703
Celgene Corporation
$646
Lilly USA, LLC
$614
Seagen Inc.
$591
Merck Sharp & Dohme Corporation
$560
BeiGene USA, Inc.
$433
Daiichi Sankyo Inc.
$399
Bayer HealthCare Pharmaceuticals Inc.
$388
GENZYME CORPORATION
$346
EMD Serono, Inc.
$304
Takeda Pharmaceuticals U.S.A., Inc.
$298
Foundation Medicine, Inc.
$294
Gilead Sciences, Inc.
$275
Regeneron Healthcare Solutions, Inc.
$265
AngioDynamics, Inc.
$260
Mirati Therapeutics, Inc.
$253
Genentech USA, Inc.
$250
Rigel Pharmaceuticals, Inc.
$209
AbbVie Inc.
$196
Janssen Pharmaceuticals, Inc
$181
SOBI, INC
$159
TAIHO ONCOLOGY, INC.
$141
PUMA BIOTECHNOLOGY, INC.
$136
Genmab U.S., Inc.
$135
Hologic, LLC
$125
Bayer Healthcare Pharmaceuticals Inc.
$116
Stemline Therapeutics Inc.
$112
AVEO Pharmaceuticals, Inc.
$105
Myovant Sciences Inc.
$90
Alexion Pharmaceuticals, Inc.
$90
Adaptive Biotechnologies Corporation
$86
Kyowa Kirin, Inc.
$84
Taiho Oncology, Inc.
$67
GlaxoSmithKline, LLC.
$57
Aveo Pharmaceuticals, Inc.
$51
Ipsen Biopharmaceuticals, Inc
$46
Sumitomo Pharma America, Inc.
$45
AbbVie, Inc.
$42
JAZZ PHARMACEUTICALS INC.
$41
ABBVIE INC.
$39
Advanced Accelerator Applications
$39
SHIELD THERAPEUTICS INC
$25
Apellis Pharmaceuticals, Inc.
$23
Immunocore Limited
$23
Blueprint Medicines Corporation
$22
Coherus Biosciences Inc.
$21
Jazz Pharmaceuticals Inc.
$19
TG Therapeutics, Inc.
$18
Sobi, Inc
$18
Ironwood Pharmaceuticals, Inc
$18
Verity Pharmaceuticals Inc.
$17
Agios Pharmaceuticals, Inc.
$17
Mission Pharmacal Company
$16
Top 3 companies account for 74.1% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AFINITOR · ALUNBRIG · ANGIODYNAMICS · AUGTYRO · Abraxane · Aimovig · Alecensa · BAVENCIO · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CREON · CYRAMZA · Cabometyx · CitraNatal · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENTRESTO · ERBITUX · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · GAVRETO · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · INREBIC · Inrebic · JAKAFI · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Linzess · Lonsurf · Lutathera · MEKINIST · MONJUVI · MVASI · NANOKNIFE · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OPDIVO · OPDUALAG · ORENCIA · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pomalyst · Prolia · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · SANDOSTATIN · SAPHNELO · SARCLISA · SCEMBLIX · SPRYCEL · SYMBICORT · SYNTHROID · Sexually Transmitted Infectious Disease · Stivarga · Synthroid · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TEPMETKO · TEVIMBRA · TUKYSA · Tavalisse · Tazverik · Tecentriq · Trelstar · Trodelvy · Turalio · UKONIQ · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Vitrakvi · Vyloy · XALKORI · XARELTO · XGEVA · XTANDI · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for hematology & oncology in NY.
Geographic Context
Hematology & oncology specialists within 10 mi
727
Per 100K population
27.5
County median income
$78,548
Nearest hospital
MAIMONIDES MEDICAL CENTER
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Guo is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 7% of NY peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Guo experienced with complete blood count (cbc) with differential?
Based on Medicare claims data, Dr. Guo performed 280 complete blood count (cbc) with differential services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Guo receive payments from pharmaceutical companies?
Yes. Dr. Guo received a total of $106,852 from 66 companies across 1,015 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Guo's costs compare to other hematology & oncology specialists in Brooklyn?
Dr. Guo's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Guo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Brooklyn
Browse hematology & oncology specialists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology